These data suggested that elevated SOCS3 expression is positively associated with enhanced perfusion in GBM, highlighting the potential of integrating SOCS3 expression levels into radiogenomic studies to achieve a more accurate noninvasive molecular profiling strategy for GBM based on perfusion MRI workup. This evidence concerns the gene SOCS3 and glioblastoma.